{"transactions":[{"id":3459082,"issuer":{"id":155932,"kind":"organization","name":"Telemynd, Inc.","symbol":"NONE"},"owners":[{"id":155944,"kind":"person","name":"Unanue Peter","position":1,"cik":"0001717633","reported_name":"Unanue Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-07-18T18:51:43.000Z","date":"2019-07-16","kind":"other","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reporting person received his shares of Series A Preferred Stock pursuant to an Exchange Agreement with MYnd and Telemynd under which he exchanged previously held securities for shares of Series A Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person received his shares of Series A Preferred Stock pursuant to an Exchange Agreement with MYnd and Telemynd under which he exchanged previously held securities for shares of Series A Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of Series A Preferred Stock have no expiration date and are convertible at any time at the election of the Reporting Person without payment of further consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares of Series A Preferred Stock have no expiration date and are convertible at any time at the election of the Reporting Person without payment of further consideration."}],"balance_after":50000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-19-013145","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1717633/000121390019013145/ownership.xml","form_type":"4"}},{"id":3459081,"issuer":{"id":155932,"kind":"organization","name":"Telemynd, Inc.","symbol":"NONE"},"owners":[{"id":155944,"kind":"person","name":"Unanue Peter","position":1,"cik":"0001717633","reported_name":"Unanue Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-18T18:51:43.000Z","date":"2019-07-16","kind":"other","acquired":true,"shares":126627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Telemynd, Inc. (\"Telemynd\") was formerly a wholly-owned subsidiary of MYnd Analytics, Inc. (\"MYnd\"). On July 15, 2019, pursuant to the Amended and Restated Separation and Distribution Agreement, dated as of March 27, 2019, between MYnd and Telemynd, the Reporting Person received a pro rata distribution of common stock of Telemynd."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Telemynd, Inc. (\"Telemynd\") was formerly a wholly-owned subsidiary of MYnd Analytics, Inc. (\"MYnd\"). On July 15, 2019, pursuant to the Amended and Restated Separation and Distribution Agreement, dated as of March 27, 2019, between MYnd and Telemynd, the Reporting Person received a pro rata distribution of common stock of Telemynd."}],"balance_after":126627,"source":{"system":"sec-edgar","filing":"0001213900-19-013145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717633/000121390019013145/ownership.xml","form_type":"4"}},{"id":3793780,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155944,"kind":"person","name":"Unanue Peter","position":1,"cik":"0001717633","reported_name":"Unanue Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-10-11T00:07:10.000Z","date":"2018-10-08","kind":"grant","acquired":true,"shares":30000,"price":1.38,"value":41400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The above restricted shares were granted under Mynd Analytics, Inc.'s (the \"Company\") Amended and Restated 2012 Omnibus Incentive Compensation Plan and vest quarterly."}],"balance_after":126627,"source":{"system":"sec-edgar","filing":"0001615774-18-010693","document":"s113209_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418010693/s113209_form4.xml","form_type":"4"}},{"id":3807908,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155944,"kind":"person","name":"Unanue Peter","position":1,"cik":"0001717633","reported_name":"Unanue Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2018-09-27T00:05:09.000Z","date":"2018-09-24","kind":"grant","acquired":true,"shares":27027,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting Person purchased 27,027 units at a price of $1.85 per unit, with each unit consisting of (i) one share of Common Stock and (ii) one Common Stock Purchase Warrant to purchase one share of Common Stock for $2.00 per share."}],"balance_after":27027,"derivative":{"exercise_price":2,"exercise_date":"2019-03-24","expiration_date":"2023-09-23","underlying":"Common Stock","underlying_shares":27027},"source":{"system":"sec-edgar","filing":"0001615774-18-010012","document":"s112893_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418010012/s112893_form4.xml","form_type":"4"}},{"id":3807907,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155944,"kind":"person","name":"Unanue Peter","position":1,"cik":"0001717633","reported_name":"Unanue Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-27T00:05:09.000Z","date":"2018-09-24","kind":"grant","acquired":true,"shares":27027,"price":1.85,"value":49999.95,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"27,027 shares of Common Stock and Warrants to purchase 27,027 shares of Common Stock for $2.00 were purchased by the Reporting Person for an aggregate of $50,000 pursuant to a Subscription Agreement, dated September 21, 2018 (the \"Subscription Agreement\"), between the Issuer and the investors party thereto."}],"balance_after":96627,"source":{"system":"sec-edgar","filing":"0001615774-18-010012","document":"s112893_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418010012/s112893_form4.xml","form_type":"4"}},{"id":3914652,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155944,"kind":"person","name":"Unanue Peter","position":1,"cik":"0001717633","reported_name":"Unanue Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-31T00:27:37.000Z","date":"2018-05-25","kind":"grant","acquired":true,"shares":4500,"price":2.27,"value":10215.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 25, 2018, the Board of Directors (the \"Board\") of MYnd Analytics, Inc. granted the indicated number of restricted shares (the \"Shares\") in lieu of the remaining amount of the Reporting Person's Board fee for the 2017-2018 fiscal year. The Shares were issued pursuant to the MYnd Analytics, Inc. Amended and Restated 2012 Omnibus Incentive Compensation Plan."}],"balance_after":69600,"source":{"system":"sec-edgar","filing":"0001615774-18-004582","document":"s110527_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418004582/s110527_form4.xml","form_type":"4"}},{"id":3977716,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155944,"kind":"person","name":"Unanue Peter","position":1,"cik":"0001717633","reported_name":"Unanue Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2018-04-02T23:18:37.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":50000,"price":6250,"value":312500000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"50,000 shares of Series A Preferred Stock and Warrants to purchase 50,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $100,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the \"Subscription Agreement\"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Warrant entitles its holder to purchase one share of Common Stock at an exercise price of $2.34 per share, subject to adjustment, at any time commencing on March 29, 2018 and expiring on March 29, 2023 (or earlier upon redemption or liquidation)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Warrant entitles its holder to purchase one share of Common Stock at an exercise price of $2.34 per share, subject to adjustment, at any time commencing on March 29, 2018 and expiring on March 29, 2023 (or earlier upon redemption or liquidation)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Warrant entitles its holder to purchase one share of Common Stock at an exercise price of $2.34 per share, subject to adjustment, at any time commencing on March 29, 2018 and expiring on March 29, 2023 (or earlier upon redemption or liquidation)."}],"balance_after":50000,"derivative":{"exercise_price":2.34,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001615774-18-002321","document":"s109515_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418002321/s109515_form4.xml","form_type":"4"}},{"id":3977715,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155944,"kind":"person","name":"Unanue Peter","position":1,"cik":"0001717633","reported_name":"Unanue Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-04-02T23:18:37.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":50000,"price":93750,"value":4687500000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"50,000 shares of Series A Preferred Stock and Warrants to purchase 50,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $100,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the \"Subscription Agreement\"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"50,000 shares of Series A Preferred Stock and Warrants to purchase 50,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $100,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the \"Subscription Agreement\"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 50,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 50,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 50,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 50,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"50,000 shares of Series A Preferred Stock and Warrants to purchase 50,000 shares of Common Stock were purchased by the Reporting Person for an aggregate of $100,000 pursuant to a Subscription Agreement, dated as of March 29, 2018 (the \"Subscription Agreement\"), between the Issuer and the investors party thereto. The Series A Preferred Stock are convertible by the Reporting Person as of the date of the Subscription Agreement and are convertible at a conversion price of $1.875 per share."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each Share of Series A Preferred Stock is convertible, at the holder's option at any time, initially into 50,000 shares of the Issuer's Common Stock, subject to specific adjustments and limitations as set forth in the Certificate of Designation pertaining to such Series A Preferred Stock."}],"balance_after":50000,"derivative":{"exercise_price":1.875,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001615774-18-002321","document":"s109515_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577418002321/s109515_form4.xml","form_type":"4"}},{"id":4140954,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155944,"kind":"person","name":"Unanue Peter","position":1,"cik":"0001717633","reported_name":"Unanue Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-06T21:19:44.000Z","date":"2017-12-06","kind":"purchase","acquired":true,"shares":15000,"price":3.649,"value":54735.0,"ownership":{"direct":true},"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001615774-17-007165","document":"s108366_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417007165/s108366_form4.xml","form_type":"4"}},{"id":4204434,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155944,"kind":"person","name":"Unanue Peter","position":1,"cik":"0001717633","reported_name":"Unanue Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2017-09-22T00:21:03.000Z","date":"2017-09-19","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments beginning on December 19, 2017."}],"balance_after":12000,"derivative":{"exercise_price":3.6,"expiration_date":"2027-09-19","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001615774-17-005261","document":"s107567_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417005261/s107567_form4.xml","form_type":"4"}},{"id":4204433,"issuer":{"id":205,"kind":"organization","name":"Emmaus Life Sciences, Inc.","symbol":"EMMA"},"owners":[{"id":155944,"kind":"person","name":"Unanue Peter","position":1,"cik":"0001717633","reported_name":"Unanue Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-22T00:21:03.000Z","date":"2017-09-19","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50100,"source":{"system":"sec-edgar","filing":"0001615774-17-005261","document":"s107567_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/822370/000161577417005261/s107567_form4.xml","form_type":"4"}}]}